PeptiDream Inc. (PPTDF)
PeptiDream Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in Kawasaki, KN, JP. The stock last traded at $6.80, up 0.00% on the session, giving a market capitalisation of $873.7M. On trailing twelve-month figures it carries a trailing P/E of -38.03, a net margin of -18.9%. Its beta of 0.55 implies it has historically moved less than the broad market.
PeptiDream Inc. is a biopharmaceutical firm dedicated to discovering and advancing innovative therapeutic solutions, including constrained peptides, small molecules, and peptide-drug conjugates. The company utilizes its exclusive Peptide Discovery Platform System (PDPS), an advanced drug discovery engine, to propel the development of its peptide-based product pipeline. PeptiDream also maintains a collaborative research initiative and an exclusive licensing agreement with Takeda Pharmaceutical Company Limited, specifically focused on developing peptide-drug conjugates for neuromuscular disorders. Founded in 2006, the company's operations are based in Kawasaki, Japan.
PeptiDream Inc. is most often compared with the following Healthcare names: